Plain-English translation of NCT07493304 on ClinicalTrials.gov ↗ · Source last updated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
United States
Phase
Large-scale testing
Sponsor
Regeneron Pharmaceuticals
Enrollment target
~1,600 participants
Started
June 2026
Primary completion
July 2031
Age range
18 Years and older
Last updated on clinicaltrials.gov in May 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Clinical Trials Administrator
Regeneron Pharmaceuticals
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.